Crossmark

18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I

Crossref DOI link: https://doi.org/10.1007/s00259-020-05039-8

Published Online: 2020-09-16

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rosario, Pedro Weslley https://orcid.org/0000-0002-5190-382X
License Information

Text and Data Mining valid from 2020-09-16

Version of Record valid from 2020-09-16
More Information

Article History

Received: 21 August 2020

Accepted: 11 September 2020

First Online: 16 September 2020

Compliance with ethical standards

: The study was approved by the Research Ethics Committee of our institution. Informed consent was obtained from all individual participants included in the study.

: The author declares that there is no conflict of interest.

Document is current

Any future updates will be listed below